Screening programs are important for preventing cancer and reducing the burden of cancer in Norway. Two cancer screening programs have been established in Norway - BreastScreen Norway and CervicalScreen Norway. A third, ColorectalScreen Norway, is scheduled to launch autumn 2021.
The goal of our screening-based research is to offer safe and effective screening programs that lower the incidence og and/or reduce deaths caused by the cancers in question.
Our research also aims to find the best solutions for those offered screening, and increase knowledge about the advantages and disadvantages of cancer screening.
We work with these issues in a number of national and international research projects, in collaboration with clinicians, researchers and others.
Research in breast cancer screening
Research in BreastScreen Norway currently focuses on understanding the development of breast cancer tumors, the pros and cons of breast cancer screening, exploring possibilities and consequences of artificial intelligence and other technologies in screening, quality of life and long-term effects of breast cancer treatment, compression force and pressure in screening, and immigrant women's participation in the program.
- How likely are benign breast disease and premalignant lesions to progress to invasive breast cancer?
- How quickly do breast cancers grow?
- Overdiagnosis and underdiagnosis in BreastScreen Norway
- Can artificial intelligence increase accuracy and effectiveness of breast cancer screening?
- Machine Learning in BreastScreen Norway
- BADDI: Kunstig intelligens i screening med standard mammografi og tomosyntese
- Tomosynthesis – the future screening tool for breast cancer?
- Effectiveness of tomosynthesis in breast cancer screening
- Long-term effects following treatment of screen-detected versus symptomatic breast cancer
- Breast compression in BreastScreen Norway
- ImmigrantScreen
Research in colorectal cancer screening
The national screening program for colorectal cancer plans to send invitations to screening in late autumn 2021. Research on both colorectal cancer and screening will increase after the program launches.
The Cancer Registry of Norway has conducted a pilot study on colorectal cancer screening since 2012. This has provided the opportunity to conduct a number of research projects.
- Colorectal Cancer Screening
- Smertelindring ved koloskopi
- The microbiome as a colorectal cancer screening biomarker (CRCbiome)
Research in cervical cancer screening
Research in cervical cancer screening currently focuses on increasing our understanding of the effect of HPV vaccination and the prevalence of HPV among the population, exploring opportunities for personalized screening for cervical cancer, and investigate whether self-administered home testing will increase attendance in the screening program.
- Equalscreen - Increased attendance and reduced inequity in cervical cancer screening
- Forekomst av human papilloma virus (HPV) blant befolkningen
- HPV-vaksinering og screening blant kvinner født 1975-1996
- LTFU: Long-term follow up of subjects participating in the clinical trials of the HPV-vaccine
- Personalised cervical cancer screening
- Forekomst av HPV-typer blant kvinner med forstadier og livmorhalskreft
